Geneva, July 7 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000062041) titled 'Single-ingredient Vitamin D3 3200 IU versus Vitamin D3 3200 IU/Zinc/Quercetin Supplementation in Adult Indonesian Women: A Pilot Randomized Controlled Trial' on June 24.
Study Type: Interventional
Study Design:
Parallel Randomized
Primary Sponsor: Three International Wellness Technology Indonesia.
Condition:
vitamin D deficiency/insufficiency in healthy adult Indonesian women
Intervention:
Intervention group: Vitamin D3 3200 IU combined with zinc bisglycinate and quercetin phytosome (Imune), administered orally once daily for 8 weeks
Control group: Vitamin D3 3200 IU monotherapy, administered orally once ...